#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaplastic large cell lymphoma T- and null-cell types Palmoplantar pustulosis Acute myeloid leukaemia recurrent Chordoma Autologous haematopoietic stem cell transplant Liver transplant rejection Penile cancer Spinal muscular atrophy C3 glomerulopathy Von Willebrand's disease Autoimmune disorder Liposarcoma recurrent Small for dates baby Synovial sarcoma recurrent Cytokine release syndrome More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma Richter’s syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent Breast angiosarcoma – Trials in Disease Hereditary ataxia – Life with Disease VEXAS syndrome – Treatment Methylmalonic acidaemia – Treatment Kearns-Sayre syndrome – Diagnostics Alternating hemiplegia of childhood – Life with Disease Sjogren’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ceftazidime Esmolol Hydrochloride Sodium Hydrogen Carbonate VENT-03 SODIUM SULFIDE NONAHYDRATE Valganciclovir Hydrochloride ULEFNERSEN Interferon Gamma Bms-986435 Fluvastatin Sodium Arbaclofen Infliximab Linperlisib Trazodone Tazobactam KETOROLAC TROMETAMOL Ab-729 Protein C [18F]Fapi-74 Copper (64Cu) Chloride More therapies…

    Learn about Your Condition

    Biliary cancer metastatic Corticobasal degeneration Pneumothorax Underweight Cholangiosarcoma Follicular lymphoma stage IV Small intestine carcinoma Peritoneal neoplasm Peripheral artery angioplasty Alveolar rhabdomyosarcoma Cytomegalovirus infection Cardiac amyloidosis Angelman's syndrome Herpes simplex meningitis Tertiary adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej…

Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej

Ul. Terebelska 57/65, Biala Podlaska, 21-500, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Austria Czechia France Greece Italy Poland +2

  • Study Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Dexamethasone
    • Dexamethasone Ph. Eur.
    Austria Belgium Czechia Denmark France Germany +7

  • Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • ALKYLATING AGENTS
    • ANTIMETABOLITES
    • Imetelstat Sodium
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

    Not recruiting

    2 1
    Investigated Drugs:
    • Ponsegromab
    Bulgaria Poland Slovakia Spain

  • Study Comparing Nivolumab and Cabozantinib with Sunitinib for Patients with Untreated Advanced Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Cabozantinib
    • Ipilimumab
    • Nivolumab
    Czechia Germany Greece Italy Poland Romania +1

  • Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    • Rituximab
    Austria Bulgaria Czechia France Hungary Italy +4

  • Study of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Romiplostim
    Bulgaria France Greece Italy Poland Portugal +2

  • Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Italy Poland Spain

  • Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Glucose Monohydrate
    • Sodium Chloride
    • Topotecan
    Austria Belgium Bulgaria Germany Greece Hungary +2

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Apixaban
    • Milvexian
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!